Mabwell (Shanghai) Bioscience Co (HKSE:02493) Other Current Receivables: HK$143.2 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02493 Mabwell (Shanghai) Bioscience Co Ltd HKSE:02493
43 GF Score
Price HK$22.50
GF Value HK$95.37
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Mabwell (Shanghai) Bioscience Co Other Current Receivables?

Mabwell (Shanghai) Bioscience Co HKSE:02493 -1.06% 43 Other Current Receivables is HK$143.2 Mil as of Mar. 2026. GuruFocus rates HKSE:02493 with a GF Score™ of 43/100 and a GF Value™ of HK$95.37 (Possible Value Trap). The stock has 5 warning signs investors should review.

Mabwell (Shanghai) Bioscience Co's Other Current Receivables for the quarter that ended in Mar. 2026 was HK$143.2 Mil.

Mabwell (Shanghai) Bioscience Co's quarterly Other Current Receivables declined from Sep. 2025 (HK$139.20 Mil) to Dec. 2025 (HK$136.21 Mil) but then increased from Dec. 2025 (HK$136.21 Mil) to Mar. 2026 (HK$143.21 Mil).

Mabwell (Shanghai) Bioscience Co's annual Other Current Receivables declined from Dec. 2023 (HK$122.79 Mil) to Dec. 2024 (HK$106.82 Mil) but then increased from Dec. 2024 (HK$106.82 Mil) to Dec. 2025 (HK$136.21 Mil).

Mabwell (Shanghai) Bioscience Co Other Current Receivables Related Terms

Mabwell (Shanghai) Bioscience Co Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Mabwell (Shanghai) Bioscience Co's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mabwell (Shanghai) Bioscience Co Other Current Receivables Chart

Mabwell (Shanghai) Bioscience Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only 40.42 92.30 122.79 106.82 136.21

Mabwell (Shanghai) Bioscience Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 128.12 116.08 139.20 136.21 143.21
HKSE:02493
43GF Score
Mabwell (Shanghai) Bioscience Co Ltd HKSE:02493
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mabwell (Shanghai) Bioscience Co Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of HK$143.2 Mil mean?
Mabwell (Shanghai) Bioscience Co (HKSE:02493) has a Other Current Receivables of HK$143.2 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Mabwell (Shanghai) Bioscience Co and its competitors.
Is Mabwell (Shanghai) Bioscience Co's Other Current Receivables too high?
Mabwell (Shanghai) Bioscience Co's current Other Current Receivables is HK$143.2 Mil. Overall, Mabwell (Shanghai) Bioscience Co has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Mabwell (Shanghai) Bioscience Co's Other Current Receivables compare to VRTX and REGN?
Mabwell (Shanghai) Bioscience Co's Other Current Receivables of HK$143.2 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Biotechnology company?
A good Other Current Receivables depends on the Biotechnology industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Mabwell (Shanghai) Bioscience Co and its competitors. Mabwell (Shanghai) Bioscience Co's current Other Current Receivables is HK$143.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mabwell (Shanghai) Bioscience Co stock overvalued right now?
Based on GuruFocus' analysis, Mabwell (Shanghai) Bioscience Co (HKSE:02493) is currently considered Possible Value Trap. The stock's GF Value™ is HK$95.37, compared to a current price of HK$22.50 — trading 76.4% below its estimated fair value. The current Other Current Receivables is HK$143.2 Mil. Mabwell (Shanghai) Bioscience Co's overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Mabwell (Shanghai) Bioscience Co (HKSE:02493), the current Other Current Receivables is HK$143.2 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mabwell (Shanghai) Bioscience Co (HKSE:02493) Overvalued in 2026?

Based on GuruFocus' analysis, Mabwell (Shanghai) Bioscience Co stock appears to be undervalued. The current stock price of HK$22.50 is trading 76.4% below its estimated GF Value™ of HK$95.37. GuruFocus considers Mabwell (Shanghai) Bioscience Co to be Possible Value Trap.

Key valuation signals for HKSE:02493:

  • Other Current Receivables: HK$143.2 Mil
  • GF Value™: HK$95.37 vs. price of HK$22.50 (76.4% below fair value)
  • GF Score™: 43/100 with 5 warning signs

No single metric tells the full story. See the HKSE:02493 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mabwell (Shanghai) Bioscience Co Business Description

Other Exchanges 688062:China
Address No. 230, Cailun Road, Room 105, Building 2, Pilot Free Trade Zone, Shanghai, CHN, 201210
Mabwell (Shanghai) Bioscience Co Ltd is engaged in the research and development, production and sales of therapeutic biological products.
43GF Score

Get the complete analysis for HKSE:02493

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$22.50
Price
HK$95.37
GF Value